Neha Krishnamohan
CIK 1866171 · Chief Financial Officer · last filed 2026-06-09
Neha Krishnamohan is a Chief Financial Officer who has filed 21 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for ARQT, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$939.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.53M
3
21
-$939.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 27,901 | $24.38 | $680.2K | -$939.5K | 6 | 2026-06-09 |
| ARTV | Chief Financial Officer | 99,356 | $8.54 | $848.5K | $0 | 4 | 2025-11-17 |
| Kinnate Biopharma Inc. (KNTE) Delisted | CHIEF FINANCIAL OFFICER | 64,087 | $2.65 | $169.8K | $0 | 10 | 2024-03-05 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | ARQT | Grant (A) | +5,778 | $0 | EDGAR |
| 2025-11-17 | ARQT | Mixed | −1,232 | -$614.3K | EDGAR |
| 2025-11-17 | ARTV | Tax (F) | −3,490 | -$11.3K | EDGAR |
| 2025-08-18 | ARTV | Tax (F) | −7,154 | -$18.8K | EDGAR |
| 2025-06-16 | ARQT | Grant (A) | +7,609 | $0 | EDGAR |
| 2025-02-28 | ARTV | Grant (A) | +60,000 | $0 | EDGAR |
| 2024-09-13 | ARTV | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-06-18 | ARQT | Grant (A) | +10,139 | $0 | EDGAR |
| 2024-04-05 | — | Disp (D) | −64,087 | $0 | |
| 2024-03-05 | Kinnate Biopharma Inc. (KNTE) Delisted | Tax (F) | −1,506 | -$3.9K | EDGAR |